Skip to content

Train hard is smart for the heart; an exercise study on clinical outcome and mechanisms in heart failure patients

Train hard is smart for the heart; an exercise study on clinical outcome and mechanisms in heart failure patients - HIT-HF

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON35051
Enrollment
90
Registered
2010-09-22
Start date
2011-07-12
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

heartfailure

Interventions

1. moderate-intensity training (traditional training) for 12 weeks (3 times per week) 2. high-intensity training for 12 weeks (3 times per week) 3. control

Sponsors

Universitair Medisch Centrum Sint Radboud
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - heart failure class II or III (diagnosed according to the NYHA-classification) - patients must be in a stable situation (*3 month) using the same medication

Exclusion criteria

Exclusion criteria: - smokers - diabetes (type I and II) - mild renal impairment or proteinuria - hepatic impairment - hypercholesterolaemia - exercise-induced ischaemia - hypertension (grade II; >160 systolic blood pressure or >100 diastolic blood pressure) - atrial fibrillation - pre-menopausal females or those on hormone replacement therapy

Design outcomes

Primary

MeasureTime frame
-physical fitness (maximal cycling test) -NO-mediated endothelial function of the brachial artery (flow-mediated dilation) -NO-mediated endothelium-dependent and -independent dilation of the forearm resistance arteries -contribution of endothelin to the baseline forearm resistance artery vascular tone

Secondary

MeasureTime frame
-cardiac function and structure (echocardiography) -bloodparameters which have a (in)direct relation with the progression and severity of heart failure (e.g. endothelin, cholesterol, LDL, HDL, triglycerides, hs-CRP, fibrinogen, homocysteine, N-terminal pro-brain natriuretic protein)

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)